Crossmark

Postdiagnostic pretreatment risk stratification for chondrosarcoma survival using routinely available registry variables: a SEER-based temporal validation study

Crossref DOI link: https://doi.org/10.1038/s41598-026-74220-0

Published Online: 2026-10-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Qiong

Wang, Junhu

Wang, Jie

Hu, Wu

Zhao, Hongmou
Funding

Funding for this research was provided by:

Shaanxi Provincial Natural Science Foundation (2025JC-YBMS-927)

Xi'an Municipal Health Commission (No. 2025ms10)
License Information

Text and Data Mining valid from 2026-10-04

Accepted Manuscript valid from 2026-10-04
More Information

Article History

Received: 17 May 2026

Accepted: 28 September 2026

First Online: 4 October 2026

Declarations

Competing interests: The authors declare no competing interests.

Ethics approval: Ethical approval and informed consent were not required because this study used publicly available, de-identified SEER data.

Document is current

Any future updates will be listed below